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Characterizing short-wave infrared fluorescence
of conventional near-infrared fluorophores
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Xidian University, Engineering Research Center of Molecular and Neuro Imaging, School of Life Science and Technology, Ministry of Education,
Xi’an, Shaanxi, China
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Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
b

Abstract. The observed behavior of short-wave infrared (SWIR) light in tissue, characterized by relatively low
scatter and subdiffuse photon transport, has generated considerable interest for the potential of SWIR imaging to
produce high-resolution, subsurface images of fluorescence activity in vivo. These properties have important
implications for fluorescence-guided surgery and preclinical biomedical research. Until recently, translational
efforts have been impeded by the conventional understanding that fluorescence molecular imaging in the SWIR
regime requires custom molecular probes that do not yet have proven safety profiles in humans. However, recent
studies have shown that two readily available near-infrared (NIR-I) fluorophores produce measurable SWIR
fluorescence, implying that other conventional fluorophores produce detectable fluorescence in the SWIR window. Using SWIR spectroscopy and wide-field SWIR imaging with tissue-simulating phantoms, we characterize
and compare the SWIR emission properties of eight commercially available red/NIR-I fluorophores commonly
used in preclinical and clinical research, in addition to a SWIR-specific fluorophore. All fluorophores produce
measurable fluorescence emission in the SWIR, including shorter wavelength dyes such as Alexa Fluor 633 and
methylene blue. This study is the first to report SWIR fluorescence from six of the eight conventional fluorophores
and establishes an important comparative reference for developing and evaluating SWIR imaging strategies for
biomedical applications. © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.24.3.035004]

Keywords: short-wave infrared; near-infrared II window; fluorescence spectroscopy; cancer imaging; medical imaging; fluorescenceguided surgery.
Paper 180553RR received Sep. 19, 2018; accepted for publication Feb. 22, 2019; published online Mar. 8, 2019.

1

Introduction

Early reports of fluorescence imaging in the short-wave infrared
(SWIR) regime,1–3 also known as the near-infrared II (NIR-II)
window, have generated substantial interest in the biomedical
optics community. Fluorescence imaging in this regime, generally considered to extend from 1000 to 2000 nm, is characterized by reduced photon scatter, minimal tissue autofluorescence,
and wavelength-dependent absorption, which can be exploited
to optimize image resolution and depth sensitivity.4,5 Broad
efforts to leverage these favorable properties for in vivo imaging
have facilitated the development of a wide array of SWIRspecific molecular probes used for imaging tumor biomarkers6,7
and vascular dynamics2,3,6,8 in preclinical models. Although a
complete understanding of these properties and their potential
implications for biomedical imaging applications has yet to
be fully realized, these early studies suggest that SWIR imaging
may be highly advantageous for visualizing subsurface structures during fluorescence-guided surgery (FGS), noninvasive
monitoring of disease, as well as a wide array of preclinical
applications requiring information from molecular reporters.
Until recently, two characteristics of SWIR imaging presented
significant barriers to accelerating translational research efforts
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in the field. First, the high price point of specialized SWIR cameras remains a significant, though not insurmountable, barrier for
many research labs. A more significant barrier arose from the
conventional assumption that specialized molecular constructs
were required for SWIR fluorescence imaging. These molecular
probes can be difficult to obtain, usually manufactured in individual research labs (with a few commercial exceptions), and,
importantly, do not yet have pharmacokinetic and safety profiles
necessary for mid-to-late-stage translational research. These barriers have generally limited SWIR imaging to animal research in
labs with appropriate expertise.
In this context, recent investigations showing robust fluorescence emission signals in the SWIR regime from a handful of
conventional NIR-I dyes [indocyanine green (ICG), LI-COR
IRDye 800CW, and IR-12N3] represent a major development
for the field.9–11 ICG is an extensively studied fluorophore
approved for human use in several clinical indications, and
IRDye 800CW has been used widely in preclinical models and
is under clinical investigation for a variety of indications.12 The
observation that the tails of the fluorescence emission peaks
of these fluorophores are readily detectable well into the SWIR
window suggests that other common NIR fluorophores likely
produce measurable fluorescence emission in this regime.
The availability of SWIR reporters that are accessible, wellcharacterized, and have historic use in biological and human
systems could further accelerate development and evaluation
of this promising new imaging modality.
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To that end, this study aims to characterize and compare
the fluorescence emission profiles in the SWIR regime of
eight commercially available red/NIR fluorophores as well as
a SWIR-specific fluorophore. Several of these fluorophores are
either approved for clinical use or currently in clinical trials,
whereas others are commonly used for preclinical in vivo studies. Using a SWIR spectrometer, fluorescence emission spectra
for each fluorophore were examined to establish a comparative
reference of SWIR fluorescence efficiency for different excitation wavelengths. Additionally, a wide-field imaging system
was used to report SWIR fluorescence as a function of concentration in tissue-simulating phantoms. These data will be valuable in guiding the development of SWIR fluorescence imaging
strategies for biomedical applications.

2

Methods and Materials

The red/NIR-I fluorophores under investigation in this study
were selected for their general accessibility and historical use
in preclinical and/or clinical studies. ICG (Chem-Impex Int’l.
Inc., Wood Dale, Illinois) and methylene blue (Sigma-Aldrich,
St Louis, Missouri) are both approved for human use, LI-COR’s
IRDye 800CW (LI-COR Biosciences, Inc., Lincoln, Nebraska)
has undergone clinical investigation for FGS in multiple tumor
sites,12 and LI-COR’s IRDye 680RD and IRDye 700DX, as well
as the Alexa Fluor fluorophores (AF 633, AF 647, and AF 750,
ThermoFisher Scientific, Waltham, Massachusetts), are used
extensively as laboratory standards for in vitro and in vivo imaging. Finally, we included IR-m1050 (Nirmidas Biotech, Inc.,
Palo Alto, California), one of the few commercially available
SWIR-specific fluorophores.
With the exception of ICG, which was dissolved in deionized
water, all fluorophores were diluted in phosphate-buffered saline
(PBS). The absorbance spectrum for each fluorophore, acquired
using a Varian Cary® 50 Bio UV–VIS spectrophotometer
(Walnut Creek, California), was used to calculate fluorophore
dilutions. All fluorophores were diluted to a concentration of
1 μM for SWIR fluorescence spectroscopy.
A diagram of the SWIR spectroscopy system used to quantify SWIR fluorescence is shown in Fig. 1(a). The liquid
samples were prepared in standard 1-cm (3 mL) spectroscopy
cuvettes and placed in the sample interface, which positioned
illumination and collection fibers perpendicular to one another
on adjacent cuvette faces. The samples were excited with each
of the following five lasers sequentially: 635, 730, 760, 785, and
670 nm (World Star Tech, Markham, Ontario, Canada) through
a 200-μm illumination fiber. All laser power outputs were tuned
to 21 mW∕cm2 to ensure fluorescence intensity values were
comparable. Emitted light was collected using a spectroscopy
fiber bundle terminating in a linear array at the entrance of the
spectrograph. The detection system consisted of a Spectra Pro
SP2150 (Princeton Instruments, Acton, Massachusetts) spectrograph with a 300-g∕mm grating blazed at 1200 nm, coupled to
an InstaSpec IR spectroscopy camera (Newport Corporations,
Franklin, Massachusetts). This camera is a 1024 × 256 pixel
InGaAs transferred-electron electron-bombarded chargedcoupled device cooled to −50°C. The detected light passed
through an 1100-nm dichroic longpass filter (Thorlabs, Newton,
New Jersey) positioned in a filter wheel at the entrance of the
spectrometer. All measurements were acquired with a camera
gain setting of 800- and 40-ms exposure time. Data from the
sensor were binned vertically during acquisition.
Journal of Biomedical Optics

Fig. 1 Experimental configuration for (a) SWIR fluorescence spectroscopy and (b) SWIR phantom imaging. (c) Normalized absorbance
spectra of each fluorophore with overlays indicating excitation laser
wavelengths used to measure SWIR fluorescence.

For each excitation source–fluorophore combination, 10
SWIR fluorescence spectra frames were acquired sequentially
and the median of these 10 frames was computed, a common
acquisition/processing strategy for cameras with high dark
noise. Background subtraction was performed using dark count
spectra without laser illumination. Integrated fluorescence was
computed between 1130 and 1200 nm and normalized to the
maximum integrated intensity value measured for all fluorophores (ICG excited at 785 nm). Signal-to-noise-ratios (SNRs)
were calculated as the mean/(standard deviation) of the integrated intensity values of 10 frames. All measurements were
acquired using the same camera settings, laser power, and
sample preparation and thus were comparable.
To establish the feasibility of imaging SWIR fluorescence of
these fluorophores in more realistic conditions, a concentration
dilution study in tissue-simulating phantoms was completed
using a wide-field SWIR imaging system. This system, depicted
in Fig. 1(b), consists of a chosen laser source fiber coupled to a
condenser lens for illumination, and a Nirvana 640 InGaAs camera (Princeton Instruments, Trenton, New Jersey) with an 1100nm longpass dichroic filter for detection. Tissue-simulating
phantoms consisted of 5-mL liquid wells containing 1% intralipid and 1% whole blood in PBS to approximate photon scatter
and absorption of tissue, respectively, and the dye of interest.
The concentration of each dye was varied from 5 μM to 19 nM
in 50% serial dilutions. The excitation lasers used for each phantom were as follows: 635 nm for AF 633 and AF 647; 670 nm
for methylene blue, IRDye 680RD, and IRDye 700DX; 760 nm
for IRDye 800CW, AF 750, IR-m1050, and ICG. The excitation
power densities measured at the sample surface ranged between
25 and 74 mW∕cm2 depending on laser source. Five 200-ms
images were acquired for each dye concentration. Images were
scaled to the excitation intensity and baselined using the intensities measured from phantoms containing no fluorophore for
each laser, though were not adjusted based on dye absorbance.
Mean values of a region of interest in each phantom were used to
report the measured intensity as a function of dye concentration,
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and SNR was calculated as the mean/(standard deviation) of the
five frames. For each dye, linear fits and Pearson’s coefficient
were determined using measurements with SNR > 5.

3

Results

The absorbance spectra for all fluorophores under investigation
are plotted with the overlapping laser diode excitation wavelengths in Fig. 1(c). Representative SWIR fluorescence spectra
and corresponding integrated signal values are shown in
Figs. 2(a)–2(f), respectively. The characteristic longpass filter
cut-on is observable at 1100 nm in the spectral plots, and the
spectral features of these measurements are consistent with the
tails of the fluorophores’ emission peaks. The complete set of
integrated signal values was normalized to the highest signal
value (ICG excited at 785 nm) and plotted in Fig. 2(g) for every
excitation source–fluorophore pairing. For these measurements,
the maximum SNR for each dye was as follows: AF 633 = 5, AF
647 = 10, methylene blue = 6, IRDye 680RD = 22, IRDye
700DX = 4, AF 750 = 37, IRDye 800CW = 49, IR-m1050 =
38, and ICG = 38.

Inspection of Fig. 2 indicates that in spectroscopy mode
(dilute, nonturbid solutions), all fluorophores under investigation generated measurable fluorescence in the SWIR window
under proper illumination conditions, and the intensity of the
emission matched expectations based on the characteristic
absorbance spectrum of each fluorophore. As expected, fluorophores with absorbance and emission peaks at shorter wavelengths—AF 633, AF 647, methylene blue, IRDye 680RD,
and IRDye 700DX—generated the lowest signal intensities in
the SWIR window, and the highest fluorescence intensities were
observed for the longer wavelength fluorophores. The strongest
fluorescence emission signal of all fluorophores was observed
from ICG when illuminated with 785-nm excitation light,
though IRDye 800CW and IR-m1050 also showed robust fluorescence emission. These results are consistent with the absorbance spectra for each fluorophore.
Images and quantitative analysis of the tissue-simulating
phantoms, acquired with the wide-filed imaging system as
shown in Fig. 1(c), are presented in Fig. 3. Figure 3(a) shows
representative images of dye dilutions for AF 633, IRDye

Fig. 2 (a)–(c) Normalized fluorescence emission spectra and (d)–(f) corresponding integrated fluorescence signals for three excitation sources. (g) Normalized integrated SWIR fluorescence for each
fluorophore/excitation source investigated.

Journal of Biomedical Optics
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Fig. 3 (a) Representative images of SWIR fluorescence in tissue-simulating phantoms containing AF
633, IRDye 680RD, and AF 750. Each image is the median of five acquisitions. (b)–(d) Fluorescence
intensities of phantom images as a function of fluorophore concentration (error bars are standard
deviation) with linear fits and Pearson’s coefficients.

680RD, and AF 750 over a selected range of concentrations.
Qualitatively, these images show responses to changing dye
concentration indicative of sensitivity to the dyes. A quantitative
analysis of all dyes are presented in Figs. 3(b)–3(d) and confirm
the qualitative observations. These panels show the mean fluorescence intensity values of all dyes as a function of dye
concentration for 635-, 670-, and 760-nm excitation sources,
respectively, with linear fits to the data. For reference, the baseline values for phantoms without fluorophores were 1560, 820,
and 6030 counts∕s for the 635-, 670-, and 760-nm lasers,
respectively (these values were subtracted from the data shown
in Fig. 3 before plotting). The SNRs for all dyes at 156 nM were
as follows: AF 633 = 150, AF 647 = 8, methylene blue = 13,
IRDye 680RD = 22, IRDye 700DX = 16, AF 750 = 281, IRDye
800CW = 150, IR-m1050 = 221, and ICG = 119.
Examination of Fig. 3 confirms that SWIR fluorescence
from all dyes studied is readily detectable in imaging mode over
a large range of biologically relevant concentrations using a
simple imaging system. With the exception of AF647, for which
the minimum detectable concentration was between 100 and
200 nM, all dyes showed a linear response down to the lowest
concentration measured (20 nM).

4

Discussion

This study is the first to report SWIR fluorescence from AF 633,
AF 647, methylene blue, IRDye 680RD, IRDye 700DX, and
AF 750, and provides a comprehensive, quantitative comparison
of SWIR fluorescence efficiency among a catalog of commonly
used fluorophores. SWIR fluorescence was readily detectable in
nonturbid samples measured using spectroscopy and in turbid
tissue-simulating phantoms imaged with an epi-illumination
Journal of Biomedical Optics

SWIR imaging system. The results from the imaging study are
particularly striking and showed a robust linear response down
to the lowest concentrations imaged (20 nM) for nearly all fluorophores. Although many of these dyes will likely be detectable
at even lower concentrations, this degree of sensitivity is already
well within the range commonly encountered during in vivo
molecular imaging.
The relatively robust SWIR fluorescence for the shorter
wavelength fluorophores (AF 633, AF 647, methylene blue,
IRDye 680RD, and IRDye 700DX) is particularly noteworthy.
Although using these shorter wavelength fluorophores to image
in the SWIR window will have inherent limitations, namely,
lower fluorescence intensity and shorter wavelength excitation
sources that may not penetrate as deeply in tissue, there are
likely specific instances for which these fluorophores offer
unique benefits. For example, methylene blue is commonly used
for sentinel lymph node mapping during cancer resection and
has been under clinical investigation for other indications.13
Thus, clinical evaluation of SWIR fluorescence for this indication could be undertaken without the need for an investigational
drug designation.
The fluorescence intensity heat map shown in Fig. 2 can be
used as a reference for comparing SWIR fluorescence efficiency
between the fluorophores tested; however, it should be noted
that some dyes were not excited at their optimal wavelength.
This can be accommodated by scaling the results in the figure
to the normalized absorbance spectra of each dye.
The general trends observed in the spectroscopy measurements and the imaging experiments were comparable, although
the relative intensities between some dyes changed. This is
most likely due to the well-known effects of changing chemical
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environments. For example, the reversal of relative intensities of
AF 633 and AF 647 between spectroscopy and phantom measurements is likely due to the fluorophores’ well-documented
behavior in lipid-based solutions.14 This represents the most dramatic change observed between two dyes, and discrepancies
between the two systems for other dyes were modest.
To our knowledge, the results herein are the first to report
and compare methodically the SWIR fluorescence from a large
catalog of red/NIR fluorophores. The observation that all
fluorophores investigated produced measurable fluorescence
expands the catalog of fluorophores that can be used for translational research of SWIR molecular imaging. Many of these
fluorophores are used in clinical practice, are under clinical investigation, or are regularly used in preclinical animal research.
Thus, the findings presented herein offer a valuable resource
to accelerate the development and evaluation of this promising
imaging modality.
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